<DOC>
	<DOCNO>NCT00925353</DOCNO>
	<brief_summary>The purpose study test hypothesis one-time application 4 % lidocaine gel ( TOPICAINE ) skin breast chest wall recommend pre-medication reduce discomfort screen mammography result adverse effect , electrocardiogram ( EKG ) change , systemically toxic plasma concentration lidocaine principal metabolite , monoethylglycinexylidide ( MEGX ) .</brief_summary>
	<brief_title>The Pharmacokinetics 4 % Lidocaine Gel When Applied Topically Breasts</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<criteria>35 year old intact skin breast chest wall sensitivity allergy lidocaine liver kidney dysfunction pregnant breast feed currently smoke chew tobacco use lidocaine product within 48 hour baseline lab , EKG , gel application exhibit neurological cardiac sign symptom prior gel application take antiarrythmic medication , ciprofloxacin , erythromycin product , oral contraceptive history WolffeParkinsonWhite Syndrome ( WPW ) congestive heart failure heart rate 60 100 beat per minute systolic blood pressure 95 180 mm Hg PR interval great 200 msec , QRS duration great 120 msec , QTc great 450 msec , evidence WPW EKG automatic implantable cardioverter defibrillator ( AICD ) cardiac pacemaker cancer , surgery , trauma , myocardial infarction past 6 month</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>lidocaine</keyword>
	<keyword>pre-medication</keyword>
	<keyword>mammography</keyword>
	<keyword>pain</keyword>
	<keyword>safety</keyword>
</DOC>